Latest Breaking News On - Atherosclerosis suppression - Page 1 : comparemela.com

uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in May 7 Annual Truist Securities Life Sciences Summit, May 4 - 5, 2021 Members of uniQure s management team will participate in virtual one-on-one investor meetings throughout the day on Tuesday, May 4. American Society of Gene and Cell Therapy (ASGCT) Virtual 2021, May 11 - 14, 2021 uniQure will have a significant presence at ASGCT with five data presentations, of which two are oral presentations including: Clinical Outcomes in Patients With and Without Pre-existing Neutralizing Antibodies to the Vector: 6-Month Data from the Phase 3 HOPE-B Gene Therapy Trial of Etranacogene Dezaparvovec on Wednesday, May 12, 6:15 - 6:30 p.m. ET.

United statesNoord hollandChiara russoMariae cantorMatt kapustaTom maloneAmerican society of geneTruist securities life sciences summitAnnual truist securities life sciences summitCell therapyPatients withWithout pre existing neutralizing antibodiesMonth dataGene targetingLipid loweringAtherosclerosis suppression